ask="5.14"
ask_size="1000"
average_daily_volume="56844"
bid="N/A"
bid_size="N/A"
book_value="1.19"
change="+0.00"
change_from_200_day_moving_average="-1.26"
change_from_50_day_moving_average="-0.57"
change_from_52_week_high="-3.55"
change_From_52_week_low="0.30"
change_in_percent="+0.00%"
close="2.92"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.90"
ebitda="-15.74M"
eps_estimate_current_year="-3.71"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.81"
ex_dividend_date="N/A"
float_shares="5652000"
high="2.95"
high_52_weeks="6.47"
last_trade_date="1/24/2017"
last_trade_price="2.92"
last_trade_size="1000"
last_trade_time="4:00pm"
low="2.62"
low_52_weeks="2.62"
market_capitalization="18.38M"
moving_average_200_day="4.18"
moving_average_50_day="3.49"
name="MabVax Therapeutics Holdings
I"
notes="N/A"
one_year_target_price="18.00"
open="2.90"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="-30.18%"
percent_change_from_50_day_moving_average="-16.27%"
percent_change_from_52_week_high="-54.90%"
percent_change_from_52_week_low="+11.45%"
previous_close="2.92"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.45"
price_per_sales="20.30"
revenue="905615.00"
shares_outstanding="6296000"
short_ratio="5.29"
stock_exchange="NCM"
symbol="MBVX"
volume="91687"
weeks_range_52="2.62 - 6.47"
